Diagnostic accuracy of qualitative MRI in 550 paediatric brain tumours: evaluating current practice in the

Luke Dixon1, Gurpreet Kaur Jandu2, Jai Sidpra3,4

  • 1Department of Neuroradiology, Imperial University Healthcare NHS Foundation Trust, London, UK.

Insights

Conventional magnetic resonance imaging (MRI) accuracy for classifying pediatric brain tumors varies significantly by tumor type and location. Computational methods are needed to improve diagnostic accuracy in challenging cases.

Area of Science:

  • Neuroradiology
  • Pediatric Oncology
  • Neuro-oncology

Background:

  • Conventional magnetic resonance imaging (MRI) plays a crucial role in the preoperative assessment of pediatric brain tumors.
  • Accurate classification of these tumors is essential for guiding treatment strategies and predicting outcomes.

Purpose of the Study:

  • To investigate the diagnostic accuracy of qualitative reporting of conventional MRI in classifying pediatric brain tumors.
  • To evaluate the concordance between MRI findings and histopathological diagnoses.

Main Methods:

  • Retrospective review of preoperative MRI reports for 550 children with intracranial lesions.
  • Assessment of concordance using the WHO 2016 classification of CNS tumors.
  • Calculation of diagnostic accuracy, sensitivity, specificity, and predictive values.

Main Results:

  • Diagnostic accuracy varied significantly by tumor type and grade.
  • Highest sensitivities were observed for ependymomas and sellar/pituitary/pineal tumors (80.65-100%).
  • Lower sensitivities were noted for meningiomas and germ cell tumors (0-56.25%), with most accurate predictions in the posterior fossa and least accurate in lobar regions.

Conclusions:

  • Conventional MRI shows variable diagnostic accuracy for pediatric brain tumors, dependent on tumor type and location.
  • Development of computational methods is recommended to enhance accuracy in specific tumor types and anatomical regions.
  • This study represents the largest series on MRI predictive accuracy for pediatric brain tumors.
Abstract